Initially, our study revealed that miR-181a decreased the 24-h urinary protein levels of CKD and ameliorated its renal damage, which was reflected in the decreased contents of albumin, uric acid, urea, serum urea nitrogen, and serum creatinine after transfection. This evidence concerns the gene ALB and chronic kidney disease.